![]() |
Name |
2-(3-Chloro-4-hydroxyphenyl)acetamide
|
Molecular Formula | C8H8ClNO2 | |
IUPAC Name* |
2-(3-chloro-4-hydroxyphenyl)acetamide
|
|
SMILES |
C1=CC(=C(C=C1CC(=O)N)Cl)O
|
|
InChI |
InChI=1S/C8H8ClNO2/c9-6-3-5(4-8(10)12)1-2-7(6)11/h1-3,11H,4H2,(H2,10,12)
|
|
InChIKey |
ORFVLZDPZCEXSD-UHFFFAOYSA-N
|
|
Synonyms |
2-(3-chloro-4-hydroxyphenyl)acetamide; CHEMBL592140; 3-chloro-4-hydroxyphenylacetamide; MEGxm0_000090; SCHEMBL5678648; ACon1_000315; 3-Chloro-4-hydroxybenzeneacetamide; BDBM50339589; 2-(3-chloro-4-hydroxy-phenyl)acetamide; NCGC00180679-01; 2-(3-chloro-4-hydroxy-phenyl)-acetamide; BRD-K17223355-001-01-3
|
|
CAS | NA | |
PubChem CID | 15038375 | |
ChEMBL ID | CHEMBL592140 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 185.61 | ALogp: | 1.0 |
HBD: | 2 | HBA: | 2 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 63.3 | Aromatic Rings: | 1 |
Heavy Atoms: | 12 | QED Weighted: | 0.734 |
Caco-2 Permeability: | -4.459 | MDCK Permeability: | 0.00004530 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.874 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.024 |
30% Bioavailability (F30%): | 0.02 |
Blood-Brain-Barrier Penetration (BBB): | 0.974 | Plasma Protein Binding (PPB): | 79.19% |
Volume Distribution (VD): | 0.707 | Fu: | 28.46% |
CYP1A2-inhibitor: | 0.532 | CYP1A2-substrate: | 0.266 |
CYP2C19-inhibitor: | 0.137 | CYP2C19-substrate: | 0.07 |
CYP2C9-inhibitor: | 0.09 | CYP2C9-substrate: | 0.68 |
CYP2D6-inhibitor: | 0.146 | CYP2D6-substrate: | 0.329 |
CYP3A4-inhibitor: | 0.06 | CYP3A4-substrate: | 0.223 |
Clearance (CL): | 13.785 | Half-life (T1/2): | 0.645 |
hERG Blockers: | 0.025 | Human Hepatotoxicity (H-HT): | 0.166 |
Drug-inuced Liver Injury (DILI): | 0.628 | AMES Toxicity: | 0.176 |
Rat Oral Acute Toxicity: | 0.049 | Maximum Recommended Daily Dose: | 0.018 |
Skin Sensitization: | 0.368 | Carcinogencity: | 0.491 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.243 |
Respiratory Toxicity: | 0.025 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000862 | ![]() |
0.730 | D0C6OQ | ![]() |
0.431 | ||
ENC000774 | ![]() |
0.512 | D08HVR | ![]() |
0.408 | ||
ENC000035 | ![]() |
0.488 | D0BA6T | ![]() |
0.392 | ||
ENC002095 | ![]() |
0.457 | D0C4YC | ![]() |
0.386 | ||
ENC000127 | ![]() |
0.408 | D0U0OT | ![]() |
0.385 | ||
ENC005854 | ![]() |
0.395 | D0T7OW | ![]() |
0.378 | ||
ENC000219 | ![]() |
0.395 | D0P7JZ | ![]() |
0.370 | ||
ENC001056 | ![]() |
0.391 | D01WJL | ![]() |
0.356 | ||
ENC000103 | ![]() |
0.386 | D0S2BT | ![]() |
0.348 | ||
ENC000325 | ![]() |
0.385 | D0Y6KO | ![]() |
0.345 |